Actionable news
0
All posts from Actionable news
Actionable news in MYL: Mylan Inc.,

A Backlash Materializes Against Soaring EpiPen Prices

Senators from both sides of the aisle are pressing Mylan (MYL) about the steadily rising costs of its lead drug, EpiPen, an emergency medication for those with anaphylaxis, or life-threatening allergies.

Sen. Chuck Grassley (R-Iowa) and Sen. Richard Blumenthal (D-Conn.) wrote letters to the pharmaceutical company, questioning drug price increases while Sen. Amy Klobuchar (D-Minn.) called for a judiciary hearing and an FTC investigation into Mylan Aug. 22.

"In the case of EpiPens, I am concerned that the substantial price increase could limit access to a much-needed medication,"...


More